G. Iacob and E. B. Dinca, Current data and strategy in glioblastoma multiforme, J Med Life, vol.2, issue.4, pp.386-393, 2009.

Q. T. Ostrom, L. Bauchet, and F. G. Davis, The epidemiology of glioma in adults: a "state of the science, review. Neuro Oncol, vol.16, issue.7, pp.896-913, 2014.

R. Stupp, W. P. Mason, and M. J. Van-den-bent, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, issue.10, pp.987-996, 2005.

, Grill J. Glioblastoma, 2007.

J. L. Fisher, J. A. Schwartzbaum, M. Wrensch, and J. L. Wiemels, Epidemiology of brain tumors, Neurol Clin, vol.25, issue.4, pp.867-890, 2007.

R. Stupp, M. Brada, M. J. Van-den-bent, J. C. Tonn, G. Pentheroudakis et al., Highgrade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup, Ann Oncol, vol.25, issue.3, pp.93-101, 2014.

W. Stummer, U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella et al.,

, Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. The lancet oncology, vol.7, pp.392-401, 2006.

W. Stummer, J. C. Tonn, and H. M. Mehdorn, Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article, J Neurosurg, vol.114, issue.3, pp.613-623, 2011.

K. Petrecca, M. C. Guiot, V. Panet-raymond, and L. Souhami, Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma, J Neurooncol, vol.111, issue.1, pp.19-23, 2013.

V. Pavlov, P. Page, and G. Abi-lahoud, Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomas, Br J Neurosurg, vol.29, issue.4, pp.524-531, 2015.

P. A. Valdes, A. Kim, and M. Brantsch, delta-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy, Neuro Oncology, vol.13, issue.8, pp.846-856, 2011.

A. Johansson, F. Faber, and G. Kniebuhler, Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis, Lasers in Surgery and Medicine, vol.45, issue.4, pp.225-234, 2013.

A. Johansson, G. Palte, O. Schnell, J. C. Tonn, J. Herms et al., 5-Aminolevulinic acidinduced protoporphyrin IX levels in tissue of human malignant brain tumors, Photochem Photobiol, vol.86, issue.6, pp.1373-1378, 2010.

W. Stummer, T. Beck, and W. Beyer, Long-sustaining response in a patient with nonresectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report, Journal of Neurooncology, vol.87, issue.1, pp.103-109, 2008.

T. J. Beck, F. W. Kreth, and W. Beyer, Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers in Surgery and Medicine, vol.39, pp.386-393, 2007.

N. Maeding, T. Verwanger, and B. Krammer, Boosting Tumor-Specific Immunity Using PDT, Cancers, vol.8, issue.10, p.91, 2016.

M. Wachowska, A. Muchowicz, and U. Demkow, Immunological aspects of antitumor photodynamic therapy outcome, Central-European Journal of Immunology, vol.40, issue.4, pp.481-485, 2015.

B. C. Wilson, P. J. Muller, and J. C. Yanch, Instrumentation and light dosimetry for intraoperative photodynamic therapy (PDT) of malignant brain tumours, Physics in Medecine and Biology, vol.31, issue.2, pp.125-133, 1986.

P. J. Dwyer, W. M. White, R. L. Fabian, and R. R. Anderson, Optical integrating balloon device for photodynamic therapy, Lasers in Surgery and Medicine, vol.26, issue.1, pp.58-66, 2000.
DOI : 10.1002/(sici)1096-9101(2000)26:1<58::aid-lsm9>3.0.co;2-v

H. Moseley, C. Mclean, S. Hockaday, and S. Eljamel, In vitro light distributions from intracranial PDT balloons, Photodiagnosis Photodyn Ther, vol.4, issue.3, pp.213-220, 2007.
DOI : 10.1016/j.pdpdt.2007.06.003

M. S. Eljamel, C. Goodman, and H. Moseley, ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers in medical science, vol.23, pp.361-367, 2008.
DOI : 10.1007/s10103-007-0494-2

M. H. Schmidt, D. M. Bajic, K. W. Reichert, T. S. Martin, G. A. Meyer et al., Light-emitting diodes as a light source for intraoperative photodynamic therapy, Neurosurgery, vol.38, issue.3, pp.556-557, 1996.

J. Akimoto, J. Haraoka, and K. Aizawa, Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas, Photodiagnosis Photodyn Ther, vol.9, issue.2, pp.91-99, 2012.
DOI : 10.1016/j.pdpdt.2012.01.001

H. A. Leroy, M. Vermandel, J. P. Lejeune, S. Mordon, and N. Reyns, Fluorescence guided resection and glioblastoma in 2015: A review. Lasers in surgery and medicine, vol.47, pp.441-451, 2015.
DOI : 10.1002/lsm.22359
URL : https://hal.archives-ouvertes.fr/hal-01182307

C. Dupont, S. Mordon, P. Deleporte, N. Reyns, and M. Vermandel, A novel device for intraoperative photodynamic therapy dedicated to glioblastoma treatment, 2017.
DOI : 10.2217/fon-2017-0261
URL : https://hal.archives-ouvertes.fr/inserm-01611670

H. A. Leroy, M. Vermandel, and B. Leroux, MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model. Lasers in surgery and medicine, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01616405